Drug product analysis

Slide

  • Do you have a risk of solid-state transition of the drug substance in your drug product?
  • Do you need to prove to authorities the robustness of your manufacturing process and the stability of your product?
  • Are you going to use less stable polymorph, cocrystal, salt or amorphous form in your formulation?
  • Will the safety, efficacy, performance, or manufacturability of the drug product be affected by solid-state form transition?
  • Do you need to evaluate the particle size of a drug substance in your product?
  • Searching for help to identify foreign particles or colour changes in your product?
  • Need to measure the thickness of a coating of your tablets or capsule walls?

We will help you to develop the analytical methods and mitigate the risks. 

Consult our Experts

Dr. Wenbo Wang
QC Chemist

Dr. Anna Shevchenko
Principal Scientist

Scroll to Top